Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment
- PMID: 30221434
- DOI: 10.1111/bdi.12690
Efficacy and tolerability of lithium for the treatment of acute mania in children with bipolar disorder: A systematic review: A report from the ISBD-IGSLi joint task force on lithium treatment
Abstract
Objectives: To assess the efficacy and tolerability of lithium for the treatment of acute mania in children and adolescent diagnosed with bipolar disorder.
Methods: A systematic literature search up to August 2017 was conducted for clinical trials that included lithium in males and females up to 18 years of age with a diagnosis of bipolar disorder and experiencing a manic or mixed episode according to standardized diagnostic criteria. The protocol was registered in PROSPERO (CRD42017055675).
Results: Four independent studies described in seven manuscripts met the inclusion criteria. Overall, 176 patients were treated with lithium either as a monotherapy or adjunct to risperidone. Efficacy results suggest that lithium may be superior to placebo (standardized mean difference [SMD] -0.42, 95% confidence interval [CI] -0.88 to 0.04), comparable to sodium divalproex (SMD -0.07, 95% CI: -0.31 to 0.18), but significantly less effective than risperidone for treating protracted manic/mixed episodes and comorbid attention-deficit hyperactivity disorder (ADHD) in prepubertal children (SMD 0.85, 95% CI: 0.54 to 1.15). Lithium was not associated with serious adverse events, and was generally well tolerated with common side effects similar to those reported in adults.
Conclusions: Limited data suggests that lithium may be an effective and tolerable treatment for some forms of paediatric mania. However, lithium is clearly inferior in efficacy to risperidone in prepubertal patients diagnosed with protracted manic/mixed episodes and comorbid ADHD. There is a lack of data concerning the efficacy and tolerability of lithium as an acute treatment for classical mania in adolescents and important clinical issues remain unaddressed.
Keywords: adolescents; bipolar disorder; children; efficacy; lithium; mania; manic episode; meta-analysis; systematic review; tolerability; treatment.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
Challenges in assessing the therapeutic benefit of lithium in children and adolescents with bipolar disorder.Bipolar Disord. 2019 Sep;21(6):556-557. doi: 10.1111/bdi.12807. Epub 2019 Jun 11. Bipolar Disord. 2019. PMID: 31141265 No abstract available.
-
Additional considerations beyond efficacy for lithium in pediatric bipolar disorder.Bipolar Disord. 2019 Sep;21(6):558-559. doi: 10.1111/bdi.12810. Epub 2019 Jul 15. Bipolar Disord. 2019. PMID: 31264283 No abstract available.
Similar articles
-
Valproate for acute mania.Cochrane Database Syst Rev. 2019 Oct 7;10(10):CD004052. doi: 10.1002/14651858.CD004052.pub2. Cochrane Database Syst Rev. 2019. PMID: 31621892 Free PMC article. Review.
-
Systematic Review and Network Meta-Analysis: Efficacy and Safety of Antipsychotics vs Antiepileptics or Lithium for Acute Mania in Children and Adolescents.J Am Acad Child Adolesc Psychiatry. 2025 Feb;64(2):143-157. doi: 10.1016/j.jaac.2024.07.920. Epub 2024 Aug 9. J Am Acad Child Adolesc Psychiatry. 2025. PMID: 39128561
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
Lithium for acute mania.Cochrane Database Syst Rev. 2019 Jun 1;6(6):CD004048. doi: 10.1002/14651858.CD004048.pub4. Cochrane Database Syst Rev. 2019. PMID: 31152444 Free PMC article.
-
A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.Arch Gen Psychiatry. 2012 May;69(5):515-28. doi: 10.1001/archgenpsychiatry.2011.1508. Epub 2012 Jan 2. Arch Gen Psychiatry. 2012. PMID: 22213771 Free PMC article. Clinical Trial.
Cited by
-
Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood- related Disorders: A Systematic Review of Randomized Controlled Trials.Curr Neuropharmacol. 2023;21(6):1329-1342. doi: 10.2174/1570159X21666230126153105. Curr Neuropharmacol. 2023. PMID: 36703581 Free PMC article.
-
Lithium Versus Other Mood-Stabilizing Medications in a Longitudinal Study of Youth Diagnosed With Bipolar Disorder.J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1146-1155. doi: 10.1016/j.jaac.2019.06.013. Epub 2019 Jul 29. J Am Acad Child Adolesc Psychiatry. 2020. PMID: 31369795 Free PMC article.
-
Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis.Acta Psychiatr Scand. 2021 Oct;144(4):368-378. doi: 10.1111/acps.13346. Epub 2021 Jul 16. Acta Psychiatr Scand. 2021. PMID: 34227095 Free PMC article.
-
Valproate for acute mania.Cochrane Database Syst Rev. 2019 Oct 7;10(10):CD004052. doi: 10.1002/14651858.CD004052.pub2. Cochrane Database Syst Rev. 2019. PMID: 31621892 Free PMC article. Review.
-
Extended-Release Lithium Treatment for Adolescents with Bipolar Disorder with or Without Comorbid Autism Spectrum Disorder: Protocol of a Longitudinal Prospective Naturalistic Study for the Assessment of Efficacy and Tolerability.J Clin Med. 2024 Oct 17;13(20):6196. doi: 10.3390/jcm13206196. J Clin Med. 2024. PMID: 39458145 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous